Skip to content
Open access

Decreased cerebral metabolic rate of oxygen (CMRO2) is associated with increased tau deposition in Alzheimer's disease

Jul 2026 · Alzheimer's & Dementia · Vol 18 · 0 citations · 50 references
Medicine

Abstract

Transgenic Alzheimer's (AD) mouse models and post mortem studies have shown that tau pathology disrupts the mitochondrial electron transport chain and results in mitochondrial damage and synaptic dysfunction. We assessed whether magnetic resonance imaging (MRI)‐derived measures of oxygen metabolism, oxygen extraction fraction (OEF), and cerebral metabolic rate of oxygen (CMRO2) were associated with tau deposition in vivo.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.